Sminu Bose, MD

18 posts

Sminu Bose, MD

Sminu Bose, MD

@SamBoseMD

Gynecologic Medical Oncologist at @MSKcancercenter Focus in uterine #sarcoma 📚 @columbiacancer @HopkinsMedicine Tweets are my own

New York, NY Katılım Mayıs 2022
95 Takip Edilen80 Takipçiler
Sminu Bose, MD retweetledi
Brian Chernak, MD
Brian Chernak, MD@BrianChernak·
Today marks 1 year since the passing of my program director (and many others) Dr. #MarkHeaney, who was a world expert in #mastcelldisorders, #MPN, and #AML for 30+ years, completely committed to patients, education, and family. Would love to hear stories from others to honor him!
Brian Chernak, MD tweet media
New York, NY 🇺🇸 English
0
4
25
5.9K
Sminu Bose, MD
Sminu Bose, MD@SamBoseMD·
So proud of @KristineLacuna for being awarded an #ASCO23 Young Investigator Award, receiving a Conquer Cancer Merit Award, and presenting posters for not one but TWO clinical trials sponsored by NCI CTEP. What a rockstar 🤩 #sarcoma
Sminu Bose, MD tweet mediaSminu Bose, MD tweet media
English
0
3
13
2.1K
Sminu Bose, MD
Sminu Bose, MD@SamBoseMD·
Such a unique experience this past week at the @AACR @ASCO #MCCR22 #Vail workshop. Met amazing oncologists from around the world, learned about clinical trial design with the best PDG, and got to rep @columbiacancer with some of my favorite people ☺️
Sminu Bose, MD tweet mediaSminu Bose, MD tweet mediaSminu Bose, MD tweet media
English
1
2
35
0
Breelyn Wilky, MD 🎗
Breelyn Wilky, MD 🎗@breelynwilkyMD·
This was solid data and discussion- one of the best presentations of the meeting. Congrats to the investigators and Sminu Bose who positively nailed this talk.
Andrea Espejo-Freire MD@AndreaEspejoMD

RAD51 foci formation predicts DNA damage repair deficiency in #leiomyosarcoma. Awesome data presented by Sminu Bose from @ColumbiaMedic @DrCeSarcoma @JTrentMDPhD @SylvesterCancer @PriscilaBCMD @breelynwilkyMD @dileo_palma @GinaDAmatoMD1

Chicago, IL 🇺🇸 English
1
1
19
0
Sminu Bose, MD retweetledi
Jon Trent, MD, PhD
Jon Trent, MD, PhD@JTrentMDPhD·
Congrats Dr. Sam Bose on identifying lack of Rad51 and WES alterations associated with favorable outcome EFS in patients with uterine #leiomyosarcoma #ASCO22 #Sarcoma
Jon Trent, MD, PhD tweet mediaJon Trent, MD, PhD tweet mediaJon Trent, MD, PhD tweet mediaJon Trent, MD, PhD tweet media
English
1
13
29
0
Sminu Bose, MD retweetledi
Pawel Sobczuk
Pawel Sobczuk@pawel_sobczuk·
Durable responses (ORR 27%) to temozolomide and olaparib in uLMS Markers of response? - WES alterations, HRD score, functional assays? 🔸RAD51 functional assays seems the most promising @SamBoseMD #sarcoma #lms #asco22
Pawel Sobczuk tweet mediaPawel Sobczuk tweet mediaPawel Sobczuk tweet mediaPawel Sobczuk tweet media
English
0
3
7
0

Keşfet

@ASCO @ConquerCancerFd @quadwfoundation @KristineLacuna @AACR @columbiacancer @DrDawnHershman @breelynwilkyMD